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INTRODUCTION
Nowadays the diabetes mellitus (DM) is one of the most 
important medical and social problems that concerns 
the most economically developed countries of the world. 
According to the World Health Organization, 108 million 
of adults worldwide suffered from DB in 1980, and in 
2014 – 422 million. The incidence rate has almost dou-
bled for this period: the number of adults with diabetes 
has increased from 4.7% to 8.5%. It can be caused by the 
nutritional disorders, as well as by the risk factors, linked 
to them, such as overweighting and obesity. Over the last 
decade, the incidence rate of DM has increased faster in 
low- and middle-income countries compared to more 
developed countries [1-5]. According to the International 
Diabetes Federation, about 592 million people will suffer 
from DB by 2035 [6].
Diabetic foot syndrome is one of the most serious com-
plications of DM. Condition of microcirculatory bed is 
extremely important for development degenerative and 
necrotic changes of epithelium in DM with formation 
of feedback mechanism between condition of microcir-
culatory bed and metabolic disorders [7]. Importance of 
sufficient blood supplying is described in connection with 
endothelial function and nitric oxide synthase synthesis 
with different origin of necrotic changes even in immune 
and autoimmune process could be also explained as con-
sequences of condition of microcirculatory bed with ulcer-
ative process formation [8,9]. Microcirculation disorders 
caused by DM are characterized by significant changes in 
microangioarchitecture with uneven congestion, reduced 
specific volume of vessels, thickening of vascular walls and 
inflammatory changes [7,9]. 
Development of the trophic ulcers of the lower limbs is 
typical manifestation of this disease, that reduces the quali-
ty of life and leads to the disability and significant financial 
expenses for the treatment. 16-18% of the patients with DM 
suffer from the lower limbs ulceration, and 28% of cases 
end with the various types of amputations [2,4,10-12]. It is 
known that 80-90% of patients, who need a high amputa-
tion due to DM despite the long-term treatment, suffered 
from the chronic ulceration. Despite various treatment 
methods and the wide range of medications, a problem of 
trophic ulcers treatment still remains unsolved [4-6,13-15]. 
Thus, the unsatisfactory treatment of the trophic ulcers 
of lower limbs, as well as the significant level of disability 
and financial expenses for treatment prove the importance 
of this problem. The use of the growth factors that are 
contained in platelet α-granules seems to be a promising 
direction in the treatment of the diabetic foot ulcers [16]. 
Recently, the platelet-rich plasma (PRP) enriched with the 
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ABSTRACT
The aim: Was following: the improvement of the treatment results of the lower limbs ulcers, caused by the diabetes mellitus by using our technique of the platelet-rich 
plasma application; the study of the features of the morphological and immunohistochemical changes, and the effect of the growth factors of the platelet-rich plasma on the 
regeneration and healing of the ulcers. 
Materials and methods: 38 patients with the trophic ulcers of the lower limbs, caused by diabetes mellitus were involved in the study. To assess the morphological features 
of the reparative processes before and after the treatment with PRP, the histological and immunohystochemical studies of the biopsy specimen of ulcers were carried out. 
Results: The total epithelialization of the ulcers in the patients from the main group was achieved on 46.5 day, and in the comparison group – 81.7 day. The light and optical 
study of the specimen of the main group, using the autologous platelet-rich plasma revealed the elimination of the destructive changes and reduction of the mixed-cellular 
infiltration compared to the patients from the comparison group. The immunohystochemical study revealed the increase of the growth factors receptors.
Conclusions: The usage of the autologous platelet-rich plasma in the treatment of the trophic ulcers results in the rapid regeneration by the decrease of the destructive and 
inflammatory changes as well as the improvement of the vascularization.
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growth factors is offered as a substrate that stimulates the 
reparative processes in the tissues [17]. The concentration 
of the growth factors in PRP is significantly high. The de-
granulation of the platelet α-granules leads to the release 
of the platelet-derived growth factor (PDGF), platelet-de-
rived endothelial growth factor (PDEGF), transforming 
growth factor (TGF), vascular endothelial growth factor 
(VEGF), platelet-derived angiogenesis factor (PDAF) and 
epidermal growth factor (EGF). These biologically-active 
substances activate the proliferation of the epidermal cells 
and endotheliocytes, stimulate the angiogenesis, collagen 
synthesis and fibroblast proliferation [18-22]. Taking into 
account the abovementioned facts, the PRP is applied 
in traumatology, dentistry, surgery, and cosmetology to 
stimulate the tissue regeneration. However, the ways of the 
reparative process are insufficiently studied. The features 
of the ulceration, as well as its area, features of the arterial 
blood circulation and the presence of the related diseases 
have not been considered in their use [23-28].
Thus, it is obvious that the treatment of the trophic ulcers, 
caused by DM is an actual problem that requires the new 
treatment approaches for its solving.
THE AIM
Object of the study was following: the improvement of the 
treatment results of the lower limbs ulcers, caused by the 
diabetes mellitus by using our technique of the platelet-rich 
plasma application; the study of the features of the mor-
phological and immunohistochemical changes, and the 
effect of the growth factors of the platelet-rich plasma on 
the regeneration and healing of the ulcers. 
MATERIALS AND METHODS
38 patients with the trophic ulcers of the lower limbs, 
caused by DM were examined and given treatment at 
the vascular surgery and surgical departments of Sumy 
regional clinical hospital. The conservative treatment was 
carried out with the use of PRP. The average disease dura-
tion in the patients was more than 18 years. There were 16 
males (42%) and 22 females (58%) patients. The patients 
were selected according to the following criteria: area of 
ulceration about 5cm2, the duration of the ulceration more 
than 4 weeks and I-II stage of the trophic ulcers according 
to Wagner’s classification (IWGDF, 2000). The patients 
with sepsis, acute myocardial infarction, osteoarticular 
apparatus affection in the area of the ulcer, critical ischemia 
of the lower limbs were excluded.
The patients were divided into two groups. The experi-
mental (main) group (I) consisted of 20 patients (8 males 
and 12 females patients). After receiving the agreement 
their standard treatment was complemented by the us-
age of PRP. The comparison (II) group consisted of 18 
patients (8 males and 10 females patients) who received 
the standard treatment: sanitation of the ulcers (treatment 
with the antiseptic, necretomy), correction of the car-
bohydrate exchange (antihyperglycemic drugs, insulin), 
antibiotics treatment (cephalosporins, fluroquinolones, 
metronidazoles, depending on the bacterial flora), vas-
cular drugs (vasoprotective drugs, vasodilating agents, 
disaggregants), unload of the pressure from the foot with 
a help of orthotics.
The PRP was obtained by two-step centrifugation method. 
At the first step, the centrifugation lasted for 15 minutes with 
the rotation speed of 1000 rpm. It allowed obtain the mixture 
Fig 1. Fragment of the foot ulceration in the comparison group. Histological 
(hematoxylin and eosin staining (A)) and immunohystochemical 
(determination of CD31 (B), Podoplanin (C) and VEGF(D) receptors) studies 
of the serial tissue specimens. Magnification × 100.
Fig 2. Fragment of the foot ulceration in the comparison group. Histological 
(hematoxylin and eosin staining (A)) and immunohystochemical 
(determination of CD31 (B), Podoplanin (C) and VEGF(D) receptors) studies 
of the serial tissue specimens. Magnification ×400.
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of plasma with the low concentration of the platelet. At the 
second step, the tubes with the mixture of the top and middle 
layers of the obtained concentrate have been centrifuged at 
1700 rpm for 10 minutes. The bottom layer of the obtained 
mixture was collected in a separate sterile syringe. The frac-
tion that contained the largest number of platelets was used 
for the treatment. A series of 5-10 injections of 0.2 ml of PRP, 
activated with the 10% solution of CaC1 were given around 
the trophic ulcer at 10 mm from its borders. The injections 
were made on 5th, 10th and 20th day of the treatment. This 
technique was supplemented by the local PRP applications 
that were carried out during 15 days at the intervals of 2 days.
To assess the morphological features of the reparative pro-
cesses in the soft tissues in the area of the ulcers before and after 
PRP treatment, the histological study of the biopsy samples, 
collected on the edge of the healthy tissue – the ulcers, by using 
hematoxylin and eosin staining method was carried out. The 
epidermization, vascularization and inflammatory infiltration 
of the ulcerative defect were assessed during the study.
Taking into account the blood supply peculiarities in the 
regenerating tissue and release of the VEGF that influence the 
healing speed, the immunohystochemical study of the follow-
ing receptors was carried out: CD31 (clone 1A10, dilution 1 : 
50) that is the marker of the existing and newly formed vessels, 
Podoplanin (clone 4D5aE5E6, dilution 1 : 200) the marker of 
the lymphatic vessels and VEGF (polyclonal, dilution 1 : 200) 
the marker of vessel endothelial growth.
The ulceration area was measured by using the Kundin 
method. Thus, the length and the width of the ulcers were 
assessed in such way that the biggest obtained measures 
were located on the perpendicular axis. The area was cal-
culated by the following formula: S = L × W × 0.785, where 
L is the length of the ulcer and W – the ulcer’s width.
Statistical processing of the results was carried out by 
using the Student’s t-test. The difference between the mean 
values at p < 0.05 was taken as a reliable value.
RESULTS
The morphological studies of the samples, stained with 
hematoxylin and eosin revealed the different regeneration 
of the trophic ulcers at different periods. In the main group, 
Fig 3. Fragment of the foot ulceration in the main group. Histological 
(hematoxylin and eosin staining (A)) and immunohystochemical 
(determination of CD31 (B), Podoplanin (C) and VEGF(D) receptors) studies 
of the serial tissue specimens. Magnification × 100.
Fig 4. Fragment of the foot ulceration in the main group. Histological 
(hematoxylin and eosin staining (A)) and immunohystochemical 
(determination of CD31 (B), Podoplanin (C) and VEGF(D) receptors) studies 
of the serial tissue specimens. Magnification × 400.
Fig 5. Dynamics of trophic ulcer healing under standard treatment and 
using PRP.
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the rapid epithelialization of the defect, “maturation” of the 
granulation tissue, elimination of the destructive changes 
as well as the reduction of the mixed-cellular inflammatory 
infiltration was observed due to the use of PRP, compared 
to the patients from the comparison group. (Fig. 1-4- A).
During the immunohistochemical study, the denser vas-
cularization both in the regenerating tissue and surround-
ing areas was revealed in the main group (CD 31-positive 
cells). The vascular component was presented by the cap-
illaries, venules and arterioles, located in the granulation 
tissue and surrounding areas (Fig. 1-4- B).
The study of Podoplanin receptors allowed visualize the 
lymphatic vessels. Their number was significantly higher 
in the samples, obtained from the patients which used 
PRP (Fig. 1-4- C).
The immunohistochemical study of VEGF receptors 
revealed endothelial expression in the regenerating tissue 
in the patients from the main group. Besides, some parts 
of cells of the stromal component of the regenerator were 
VEGF- positive. The number of these receptors was sig-
nificantly lower in the comparison group that indicates 
the prevalent angiogenic potential of PRP (Fig. 1-4- D).
We considered the following clinical indicators of the 
ulcer healing: the intensity of the inflammation, formation 
of the granulation tissue and the epithelialization. In first 
2 weeks of the treatment, the inflammation was less inten-
sive and the growth of the granulation tissue was activated 
that led to the healing of the ulcers. In the main group, the 
trophic ulcers decreased by 60.5% on the 30th day of the 
treatment. The damage area in the comparison group was 
reduced by 39.6% for this period, that is 1.5 times less than 
in the main group (p < 0.05). The total epithelialization of 
the ulcers in the patients from the main group was achieved 
on 46.5 day and in the comparison group – on 81.7 day (p 
< 0.05). Based on the obtained results the healing of the 
ulcers of the patients from the main group is faster in 1.7 
times (p < 0.05). The average period of the hospitalization 
of the patients from the main group was 14.6 days and for 
the comparison group – 23.6 days (p < 0.05). The criteria for 
the discharge of the patients were the following: cleaning of 
the trophic ulcer, reduced inflammation, granulation tissue 
growth and beginning of the epithelialization. 
DISCUSSION
The main principles of the treatment of the trophic ulcer, 
caused by the DM were provided in “International agree-
ment on diabetic foot”. It is a multivariate approach that 
includes the following treatment: normalization of carbo-
hydrate metabolism, unload of the foot with orthopedic 
insoles, prevention and control of infection, ulcer treatment 
(vacuum therapy), improvement of blood flow etc., aimed 
at acceleration of the ulcer healing [13,15].
Standard treatment guidelines are increasingly being 
supplemented with new immunologically safe therapeutic 
technologies. Among them, the use of autologous blood 
components is a modern promising area of medicine [29]. 
In our study we applied the combined standard treatment 
of the trophic ulcers, caused by the DM, with the use of PRP. 
Positive effect of treatment was achieved: reduced inflamma-
tion, acceleration of the ulcers epithelization. Thus, in patients 
who were treated with this technique, the healing of the ulcers 
Fig 6. The scheme the effectiveness of the trophic ulcers treatment with the use of platelet-rich plasma.
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was much faster in comparison with the patients treated 
under the standard scheme (Figure 5). The assessment of the 
morphological changes revealed the accelerated regeneration, 
maturation of granulation tissue and reduced mixed-cell 
inflammatory infiltration due to the use of PRP. Immuno-
histochemical research has shown that the additional use 
of PRP increases the number of cells that express the VEGF 
receptors in regenerating tissues. The angiogenic properties 
of this protein promote the increased vascular growth, as well 
as the increase of their density (CD31-posivite structures). 
Among them, significant parts fall to the lymphatic vessels 
(Podoplanin-positive structures). Endothelial proliferation, 
increased angiogenesis and lymphatic vessels growth lead to 
the improvement of regeneration of the tissues, both due to 
the restoration of blood flow in hypoxia-affected areas and 
normalization of the lymphatic drainage system (Figure 6).
Based on the study results, the use of PRP is a simple, effective 
and rather safe method to improve the healing of the diabetic ul-
cers. A significant number of the growth factors (vascular, throm-
bocytic, epidermal) and immunoglobulins not only increases the 
epithelization rate of the trophic ulcers but also stimulate the local, 
anti-inflammatory and immune response of the body.
CONCLUSIONS
Platelet-rich plasma, used in complex treatment of the dia-
betic trophic ulcers, accelerates the regeneration of the skin 
defect by the reduction of the destructive and inflammatory 
changes and improvement of the vascularization. This re-
duces the period of the trophic ulcers epithelialization in 
1.7 times and period of hospitalization of the patients up 
to 14.6 days compared to the comparison group (p < 0.05). 
The immunohistochemical study revealed that platelet-rich 
plasma as a source of VEGF, stimulates the vascularization 
dense of the regenerated tissues through the appearance 
of the capillaries, venules, arterioles and lymphatic vessels. 
This intensifies the positive effect of ulcers healing.
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